United States, Florida, New Port Richey – 05-28-2019 (PRDistribution.com) —
Jerome Shaunnessey is the inventor of United States Patent No 5,823,941 which was issued October 20, 1998 for an apparatus that uses a laser to vaporize a brain tumor without performing a crainiotomy and Monteris Medical of Canada, was issued United States Patent No 6,418,337 on July 9, 2002 which cited U.S. Patent No 5,823,941 as prior art. Prior art patents are patents that a patent applicant reads thoroughly to understand what it does and how it does it, to determine if his invention has already been invented.
Mr Shaunnessey filed a Criminal Referral with the;
”NATIONAL INTELLECTUALPROPERTY RIGHTS COORDINATION CENTER”
Alledging Conversion of his invention by Monteris Medical, by copying the methods and techniques on how to use the laser to kill a brain tumor without performing a crainiotomy, described in the prior art 941 patent.
The Referral states that in the Backgroud of Invention of U.S. Patent No 5,823,941 it states the following; “Another object is to provide a method for removing brain tumors without actually performing a crainiotomy” described as follows in the ‘Brain Operation Procedure’ of the 941 Patent. The method of placeing a reference pin (fiducial) in the skull of the patient and creating a three dimensional image of the brain tumor and a trajectory thru the three dimensional image of the brain tumor, then calculating the position and angle of the created trajectory relative to the reference pin (fiducial) and the method of using the calculation to position the axis of the endoscope coaxial with the trajectory, then position the deflected laser beam in a scan plane within the brain tumor and use the information in the image of the scan plane to direct the rotation of the deflected laser beam.
The Monteris United States Patent No 6,418,337 is for the invention of an apparatus that uses a laser to coagulate a brain which stated in the ‘Background Of The Invention’ The excision of tumours by hyperthermia is known’ and “it is also known that magnetic resonance imaging systems can be used by modification of the imaging sequences to determine the temperature of tissue within the image” which are known and inherent uses of the laser and MRI. of the invention of the 941 patent.
And in the detailed Description’ of the 337 patent it also stated;
“In the arrangementas shown, the apparatus is arranged for operating upon a tumour 32 within the brain 33 of the patient. The surgeon there-fore creates an opening 34 in the skull of the patient and directs the cannula 31, in the absense of the fibre 20 ,through the opening 34 to the front edge of the tumour 32”
This method is absurd and impossible to do, which indicates that in 2002, Monteris had no idea on how to use a laser to kill a brain tumor without performing a crainiotomy, but copied the methods previously described from the 941 patent to build the AutoLITT.
On October 3, 2007 Monteris published an article on the internet that stated:
“THE POTENTIAL MARKET FOR THE AUTOLITT HAS BEEN ESTIMATED TO BE AS HIGH AS $500 MILLION PER YEAR”
Why was the AutoLITT worth this much money ? Was it because the apparatus of the AutoLITT could axially position the deflected beam of laser light at the end of the probe and rotate it about the axis ? No, that by itself has no utility and is not worth a nickel.
“IT WAS WORTH THIS MUCH MONEY BECAUSE THE AUTOLITT COULD KILL A BRAIN TUMOR WITHOUT PERFORMING A CRAINIOTOMY”
Monteris was so determined to retain possesion of the AutoLITT that they filed an Ex Parte Reexamination of U.S. Patent No 5,823,941 in an attempt to invalidate it, but they failed, the Certificate was issued with Claims 1 thru 7 validated and Claim 8 amended and strengthend. Monteris now had a dillema, the AutoLITT was still an infringement of the Certificate. So what did Monteris do ? They invented the Neuroblate which is a monstrosity of wires, pulleys and gears to replace the motors of the apparatus of the AutoLITT and avoid infringement. Why did they do this ? To steal the methods and techniques on how to kill a brain tumor without performing a crainiotomy which as Monteris believed was worth $500 million per year.
In sumation, Monteris invented absolutely nothing, they changed the use of the laser and the use of the MRI of the 941 patent, which by itselve has no use at all, but copied the apparatus and the method of useing the Endoscopic Surgical Laser assembly as a trajectory guide and all of the methods and techniques on how to use the laser to kill a brain tumor without performing a crainiotomy, which was a Theft of Conversion by Monteris Medical by copying how to kill a brain tumor without performing a crainiotomy from the prior art 941 patent.
A copy of the Referral filed with the National Intellectual Property Rights Coordination Center by Jerome Shaunnessey on March 14, 2019 is available under the Freedom Of Information Act.
For the original news story, please visit https://prdistribution.com/news/american-inventor-claims-canadian-company-copied-how-to-kill-a-brain-tumor-without-performing-a-crainiotomy-from-his-us-patent.html.